Skip to main content
Caplight Logo









TATAA Biocenter

TATAA Biocenter

Private
GothenburgHealthcare & Life Scienceshttps://tataa.com/

Last Round

VC Round

Oct 1, 2023

Momentum

Top 10%

of companies Caplight tracks

Company Overview

TATAA Biocenter is a biotechnology company that provides molecular analysis services, including qPCR, dPCR, NGS, and proteomics, to support drug development and clinical research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract research organizationCROqPCRdPCRnext-generation sequencingNGSbioanalytical servicesGLP-accredited labbiomarker discoveryproteomicsassay developmentclinical trial supportlab servicesmolecular diagnosticsdrug development servicesscientific training

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TATAA Biocenter Comparables

Compare TATAA Biocenter with similar companies based on industry and business-model similarity.

TATAA Biocenter comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KCAS Bioanalytical and Biomarker Services
82%
CellCarta
78%
BioAgilytix
72%

TATAA Biocenter Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 1, 2023
GrantOct 20, 2022
Private EquityApr 30, 2021

Key People

Founding team and executive leadership

Mathias Hallin

Chief Executive Officer, Head of Finance

Executive Team

TATAA Biocenter Investors

Notable investors and investment history

TATAA Biocenter investors
InvestorRounds
VinnovaGrant
Care EquityPrivate Equity, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 105% MoM.

  • Oct 1, 2023

    Led by Care Equity

TATAA Biocenter Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TATAA Biocenter Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TATAA Biocenter's valuation, stock price, and market status.

Firmographic Details

HeadquartersGothenburg
Employee Range42
Year Founded2001
Last FundingOct 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?